Clinical trial
National Retrospective Observational Study in Patients Treated With Remdesivir Suffering From SARS-CoV-2 Hospitalized in Internal Medicine
NCT05239988 is registered in ClinicalTrials.gov with Fadoi Foundation, Italy as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- National Retrospective Observational Study in Patients Treated With Remdesivir Suffering From SARS-CoV-2 Hospitalized in Internal Medicine
- Lead sponsor
- Fadoi Foundation, Italy
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 24, 2021
- Completion date
- June 30, 2022
- Enrollment
- 1,004 (actual)
- Sites
- 30
Conditions
As the registry lists them; a condition with its own page is linked.
hospitalization